Viatris (VTRS) Long-Term Investments (2020)
Viatris (VTRS) posted quarterly Long-Term Investments of $25.0 million for Q4 2020.
Viatris (VTRS) Long-Term Investments (2020) Analysis & Trends
Viatris' Long-Term Investments history runs 1 years deep, the most recent figure standing at $25.0 million for Q4 2020.
- In Q4 2020, Long-Term Investments changed N/A year-over-year to $25.0 million; the TTM figure through Dec 2020 stood at $25.0 million (changed N/A YoY), while the FY2020 annual figure was $25.0 million, changed N/A from the prior year.
- Long-Term Investments for Q4 2020 stood at $25.0 million.
- The five-year high for Long-Term Investments was $25.0 million in Q4 2020, with the low at $25.0 million in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | 92.58 Mn |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | 63.23 Mn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 1.14 Bn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | 149.10 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | 60.00 Mn |
| 10 | Alkermes | 8.14 Bn | 7.48 Bn | 397.90 Mn | 35.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 25.00 Mn |